Maxximilk

Company Overview

Snapshot

Founded in September 2008, Maxximilk is an Israeli bio-tech firm with 1–10 employees focused on genetic improvement of dairy herds. The company was acquired by Godrej Agrovet in January 2017.

Business overview

Maxximilk specializes in agricultural biotechnology, aiming to enhance dairy farm profitability through advanced genetic solutions. The company produces in-vitro, ready-to-transfer pedigree embryos derived from high-yield cows, enabling dairy farmers to rapidly establish new herds of champion milk-producing cows. Maxximilk operates within the Agriculture & Food Technologies sector, specifically targeting the livestock and dairy industries with its breeding and genetics technology.

Strategic signal

In January 2018, Godrej Agrovet acquired a majority stake in Maxximilk, signaling a strategic move by the Indian animal feed company to integrate advanced genetic technology into its operations. This acquisition highlights the growing importance of biotechnology in enhancing agricultural productivity and provides Maxximilk with significant market access and resources for expansion, particularly in regions like India.

Company Intelligence Q&A

When was Maxximilk founded?

Maxximilk was founded in September 2008.

What is Maxximilk's core technology?

Maxximilk's core technology involves producing in-vitro, ready-to-transfer pedigree embryos from professionally inbred cows with high annual milk yields.

Which company acquired Maxximilk?

Maxximilk was acquired by Godrej Agrovet in January 2017.

Where did Maxximilk open a production facility?

Maxximilk opened a production facility in the Indian state of Maharashtra in 2017, following its partnership with Godrej Agrovet Ltd.